Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001729637-24-000004
Filing Date
2024-05-16
Accepted
2024-05-16 16:56:02
Documents
1
Period of Report
2024-04-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2257
  Complete submission text file 0001729637-24-000004.txt   3898
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Issuer) CIK: 0000797564 (see all company filings)

EIN.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1301 MOCKINGBIRD PL VIRGINIA BEACH VA 23451
Business Address
Murphy Jason (Reporting) CIK: 0002023206 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15303 | Film No.: 24956448